Vibrio vulnificus is a waterborne pathogen that was responsible for an outbreak of severe softtissue infections among fish farmers and fish consumers in Israel. Several factors have been shown to be associated with virulence. However, the transcriptome profile of the pathogen during human infection has not been determined yet. We compared the transcriptome profile, using RNA sequencing, of a human-pathogenic strain harvested directly from tissue of a patient suffering from severe soft-tissue infection with necrotizing fasciitis, with the same strain and three other environmental strains grown in vitro. The five sequenced libraries were aligned to the reference genomes of V. vulnificus strains CMCP6 and YJ016. Approximately 47.8 to 62.3 million pairedend raw reads were generated from the five runs. Nearly 84 % of the genome was covered by reads from at least one of the five runs, suggesting that nearly 16 % of the genome is not transcribed or is transcribed at low levels. We identified 123 genes that were differentially expressed during the acute phase of infection. Sixty-three genes were mapped to the large chromosome, 47 genes mapped to the small chromosome and 13 genes mapped to the YJ016 plasmid. The 123 genes fell into a variety of functional categories including transcription, signal transduction, cell motility, carbohydrate metabolism, intracellular trafficking and cell envelope biogenesis. Among the genes differentially expressed during human infection we identified genes encoding bacterial toxin (RtxA1) and genes involved in flagellar components, Flp-coding region, GGDEF family protein, iron acquisition system and sialic acid metabolism.
INTRODUCTION
Vibrio vulnificus is considered the major cause of shellfishassociated deaths in the USA (Oliver, 1989) . V. vulnificus causes severe systemic infections with considerable mortality rates, particularly among patients with chronic liver diseases (Haq & Dayal, 2005; Oliver, 2006) . However, it appears to be an opportunistic pathogen of humans and despite its abundance in marine and estuarine environments (Høi et al., 1998; Myatt & Davis, 1989; Oliver et al., 1982; Veenstra et al., 1994) human infections are relatively uncommon (Levine & Griffin, 1993) . In 1996, an outbreak of severe soft-tissue and bloodstream infections erupted in Israel among fish farmers and fish consumers. The causative pathogen was a newly described biotype, named biotype 3, of V. vulnificus (Bisharat et al., 1999) .
Analysis of data obtained from multi-locus sequence typing (MLST) showed that V. vulnificus populations are divided into two genetically distinct populations where one is dominated by environmental strains (cluster I) and the other is dominated by strains obtained from human infections (cluster II) (Bisharat et al., 2005 (Bisharat et al., , 2007b . Contemporary analysis of MLST data submitted to the V. vulnificus MLST database website (http://pubmlst.org/ vvulnificus) showed that the split into two genetically distinct populations is preserved (N. Bisharat, unpublished data) . However, phylogenetic and evolutionary analysis showed that the causative pathogen of the disease outbreak in Israel (biotype 3) displayed a mosaic structure and was placed between the two divergent clusters, being more closely related to cluster I than to cluster II strains (Bisharat et al., 2005 (Bisharat et al., , 2007b (Bisharat et al., , 2011 Bisharat, 2010) .
Despite the abundance of diverse environmental populations of V. vulnificus in Israel (Broza et al., 2009 (Broza et al., , 2012 , nearly all microbiologically confirmed infections in Israel were caused by the same biotype 3 (sequence type 8 by MLST) (Bisharat et al., 1999 (Bisharat et al., , 2005 Broza et al., 2009; Zaidenstein et al., 2008) . These observations emphasized the virulent potential of biotype 3.
Virulence of V. vulnificus has been associated with several factors: capsular polysaccharide is considered one of the most important (Oliver, 2006; Simpson et al., 1987) ; other factors include iron-uptake systems (Litwin et al., 1996) , RTX toxin (Kim et al., 2008; Lee et al., 2007) , haemolysin (Lee et al., 2004b) and lipopolysaccharide (McPherson et al., 1991) . Additional factors have been proposed as potentially associated with virulence, such as phospholipase A (Koo et al., 2007) , haemolysin-cytolysin (Gray & Kreger, 1985; Wright & Morris, 1991) and metalloproteases (Gulig et al., 2005) . A considerable body of knowledge concerning the virulence mechanisms of V. vulnificus was obtained from mutational analysis experiments using nonhuman cell lines such as mouse intestinal epithelial cells (Jeong & Satchell, 2012) , ovarian hamster cells, bovine pulmonary artery cells and peritoneal macrophages from mice (Lee et al., 2004b) , or intraperitoneally injected mice (Alice et al., 2008; Gauthier et al., 2010; Kim et al., 2005 Kim et al., , 2008 Lee et al., 2008b; Shao & Hor, 2000) . Nevertheless, it is unclear what is the exact role of the various virulent factors during human infection.
To date, three human-pathogenic V. vulnificus strains have had their genomes completely sequenced (CMCP6, YJ016 and MO6-24) (Chen et al., 2003; Kim et al., 2003; Park et al., 2011) . While these studies provided important insights into the genetic structure and organization of the bacterium, particularly how gene duplication, recombination and horizontal transfer had enriched the content of the bacterial genome during evolution, we gained little information about post-genomic processes, such as responses at the transcriptome level. In this regard, the advent of next generation sequencing technology has dramatically improved functional genomics experiments and quantitative gene expression studies (MacLean et al., 2009) .
RNA sequencing (RNA-seq) has been utilized to represent the transcriptome revealed by sequencing cDNA through next generation sequencing. Though initially described for the transcriptional map of yeasts (Nagalakshmi et al., 2008) , it has been increasingly utilized for studying bacterial genomes (Pinto et al., 2011) . RNA-seq is capable of characterizing the entire transcriptome, both quantitatively and qualitatively, of an organism, discovering new transcripts and identifying mutations, deletions and insertions, and splicing alternatives (van Vliet, 2010) .
We aimed to characterize the transcriptome profile of an invasive human-pathogenic strain of V. vulnificus obtained from infected human tissues during the acute phase of disease manifestation. We hypothesize that biotype 3 strains that have been exclusively responsible for disease outbreak in Israel could be optimal candidates to search for insights into the genotypic characteristics of V. vulnificus conferring the ability to cause disease in humans. The current study applied RNA-seq in order to characterize the set of genes differentially expressed in a biotype 3 strain directly harvested from a patient with severe infection.
METHODS
Bacterial strains, growth and RNA preparation. Four strains of V. vulnificus were used in this study. Strain VV9-09 is a biotype 3 strain isolated from an infected patient in Israel. Strain 2321 is a biotype 3 (ST-8) strain isolated from water samples of a fish pond implicated in a significant number of cases of human disease in Israel. Strain 5/I is a biotype 1, cluster II strain isolated from water samples of a fish pond in Israel. Strain 101/4 is a biotype 1, cluster I strain isolated from healthy fish in Israel.
In order to characterize the transcriptome profile of an invasive human-pathogenic V. vulnificus we sought to extract the RNA of bacteria present in infected soft-tissue matter (skin and subcutaneous tissue) or fluid contained in an infected bullae. Upon admission to the emergency room of a patient with suspected V. vulnificus infection (fish farmer or fish consumer injured during handling fish) and suffering from severe soft-tissue infection, a softtissue matter or infected subcutaneous fluid sample was obtained for analysis.
Strain VV9-09 was obtained from a 76-year-old patient with cryptogenic cirrhosis and diabetes mellitus who suffered from severe soft-tissue infection that evolved within 24 h after handling live fresh fish purchased in a local fish store. The patient presented to the emergency room in septic shock with multi-organ failure and severe soft-tissue infection evolving into necrotizing fasciitis with haemorrhagic bullae. Upon admission to the emergency room, two samples where obtained from one of the haemorrhagic bullae. One sample (500 ml) was fixed with 2 : 1 volumes (1000 ml) of RNAprotect Bacteria (Qiagen) and harvested. RNA was isolated from the pellet using an RNeasy Protect Bacteria Mini kit (Qiagen) according to manufacturer's instructions and immediately stored at 280 uC. The other sample was used for Gram staining and culture. Upon confirmation that the causative pathogen was identified as V. vulnificus, we used the extracted RNA (from the first sample) for the study. Strain VV9-09 was identified phenotypically as biotype 3 and genotypically as sequence type 8 (by MLST), the pathogen responsible for the disease outbreak in Israel. This strain (VV9-09) together with the other strains used in the study (2321, 5/I and 101/4) were grown overnight in Luria broth at 37 uC to OD 600 50.6. All cultures were fixed with 2 : 1 volumes of RNAprotect Bacteria and harvested. RNA was isolated from the pellet using an RNeasy Protect Bacteria Mini kit. RNA quality from samples was assessed using the Agilent 2100 Bioanalyser and RNA 6000 Nano kit (Agilent). Five micrograms of total RNA was enriched for mRNA with a MICROBExpress Bacterial mRNA Enrichment kit (Ambion) and the rRNA removal was verified by RNA 6000 Nano kit.
Library construction and sequencing. Library construction was done according to the 'Whole Transcriptome Library Preparation: Standard Input' protocol with a SOLiD Total RNA-seq kit (Life Technologies) with some variations as described below. The starting material was 200 ng of rRNA-depleted total RNA. RNA was fragmented with RNaseIII, cleaned up with a Purelink RNA Micro kit (Invitrogen) and checked on an Agilent 2100 Bioanalyser with RNA 6000 Pico kit (Agilent) to assess concentration and size distribution of fragmented RNA. A standard cDNA library was prepared from 100 ng fragmented RNA. Two rounds of bead capture were performed for cDNA purification and size-selection using the Agencourt AMPure XP (Beckman Coulter Genomics). Each cDNA library was amplified with 12 cycles of PCR using a different barcoded SOLiD 39 Primer from a SOLiD RNA Barcoding kit (Ambion). The amplified cDNA library was then purified with a PureLink PCR Micro kit (Invitrogen), quantified using an Applied Biosystems 7900HT Real-Time PCR System and the KAPA Quantification kit for SOLiD/ABI Prism Library (Kapa Biosystems), followed by analysis on an Agilent 2100 Bioanalyser with High Sensitivity DNA kit (Agilent).
All libraries were evenly pooled and 500 pmol of template was used for emulsion PCR in a final concentration of 0.5 pM according to the Applied Biosystems SOLiD 4 System Templated Bead Preparation Guide (PN 4448378). Sequencing was performed on the SOLiD 4 platform.
RNA-seq analysis. The five sequenced libraries were aligned to the reference genomes of V. vulnificus strains CMCP6 and YJ016, RefSeq accession numbers NC_004459 and NC_004460 for V. vulnificus CMCP6, and RefSeq NC_005128, NC_005139 and NC_005140 for V. vulnificus YJ016 and its plasmid (plasmid_pYJ016). The alignment was carried out using LifeScope Secondary Analysis software.
We used FASTX Toolkit (version 0.0.13) to remove sequence reads shorter than 20 bp and reads with low-quality bases. For gene expression determination, we performed a standard calculation of Reads Per Kilobase of Gene Per Million Mapped Reads (RPKM) which quantifies gene expression from RNA sequencing data by normalizing for total read length and the number of sequencing reads as follows: RPK5no. of mapped reads/length of transcript in kb (transcript length/1000) and RPKM5RPK/total no. of reads in one million (total no. of reads/1 000 000).
Total reads and estimation of gene expression (RPKM) values were calculated for each gene and ORF in each sample and for each bacterial strain. We used Burrows-Wheeler Aligner (BWA) (Li & Durbin, 2009 ) and BEDtools (Quinlan & Hall, 2010) on some of the samples using the reference CMCP6 and YJ016 genomes to validate the results obtained from LifeScope Secondary Analysis software. We compared the transcriptome profile of strain VV9-09 harvested directly from human tissues to the profile of the same strain and the other strains (2321, 5/I and 101/4) when grown in LB medium, then we compared the transcriptome profile of all the strains grown in LB to each other. To be considered a differentially expressed gene, the candidate gene within the human-pathogenic strain should show significant expression in comparison to at least one of the strains grown in LB. The variance analysis package DEseq (Anders & Huber, 2010) was used to systematically search the transcriptome data for the subset of differentially expressed genes. A gene was considered an upregulated gene using a cut-off value of ¢2 fold expression with a P value ,0.05 between any two samples. We have used a more stringent criterion to identify a small subset of highly differentially expressed genes (log 2 fold expression .4 and P value ,0.01) as recently used to identify the transcriptome profile of Vibrio cholerae derived from animal models (Mandlik et al., 2011.) . Fold expression was calculated based on the average M values calculated by DEseq for each gene and group of genes. Visualization of mapped reads to the reference genomes was done using SeqMonk (www.bioinformatics.babraham. ac.uk/projects/seqmonk).
The local ethics committee approved the study as part of a previous study that addressed other aspects of the disease outbreak in Israel (Bisharat et al., 2011) .
RESULTS AND DISCUSSION

RNA-seq results
Approximately 47.8 to 62.3 million paired-end raw reads were generated from the five runs. Repetitive, lowcomplexity and low-quality reads were filtered out prior to alignment to reference genomes. Between 87 and 93 % of total reads were mapped to the reference genomes, of which 52 to 78 % mapped to CDS (Table 1) . The correlation between read proportions for the vast majority of the genes was similar between replicates, indicating high reproducibility. Nearly 84 % of the genome was covered by reads from at least one of the five runs, suggesting that nearly 16 % of the genome is not transcribed or is transcribed at low levels. The number of reads mapped to each of the two chromosomes of the two reference genomes was comparable (Table 1) . However, the number of reads mapped to the reference sequence of plasmid YJ016 was significantly higher among biotype 3 strains (Table 1) . 3 000 000 2 750 000 2 500 000 2 250 000 2 000 000 1 750 000 1 500 000 1 250 000 1 000 000 750 000 500 000 250 000 0 3 250 000 1 600 000 1 400 000 1 200 000 1 000 000 800 000 600 000 400 000 200 000 0 1 800 000 Differentially expressed genes in the humanpathogenic biotype 3
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Comparing the transcriptome profile of the humanpathogenic biotype 3 (VV9-09) harvested directly from human tissue to the same strain when grown in vitro and to each of the other strains (2321, 5/I, 101/4) grown in vitro (LB medium) based on their mapping to the reference genome of V. vulnificus YJ016 (Fig. 1 ) resulted in a list of 393 genes that were upregulated (log 2 fold expression ¢1) (Table S1 , available in Microbiology Online). Read alignment to the reference CMCP6 genome showed that 378 genes were upregulated (Table S2 ). Sixty-eight identical genes were found in the two genomes, 275 genes were unique to CMCP6 and 345 genes were unique to YJ016; altogether 688 genes were upregulated during human infection. Based on the predetermined criteria for identifying a subset of highly differentially expressed genes (log 2 fold expression ¢4 and P value ,0.01), we identified 41 genes that were differentially expressed based on the alignment to the CMCP6 genome, 42 genes based on mapping to the YJ016 genome, and 40 genes that were shared by both genomes (Table 2) ; altogether, 123 genes were found to be highly differentially expressed during human infection. Sixty-three genes were mapped to the large chromosome, 47 genes mapped to the small chromosome, and 13 genes mapped to the YJ016 plasmid. Nearly 68 % of the genes were differentially expressed in at least two comparisons between the in vivo strain (humanpathogenic VV9-09) and the in vitro strains (VV9-09, 2321, 5/I and 101/4, all grown in LB); the rest,~32 %, were (Table S3) . Nearly two-thirds of the 123 genes were differentially expressed in the strain-specific comparison (index strain VV9-09 during human infection against the same strain grown in vitro) (Table S3 ).
Comparing the transcriptome profile of the index strain (VV9-09) when grown in vitro against all the other strains grown in vitro showed that nearly one-tenth of the 123 upregulated genes in vivo were also found to be differentially expressed in vitro. These included CMCP6 genes VV1_0779, VV1_2868, VV2_0993, VV2_1377 and VV2_1342, and YJ016 genes VV0136, VV0137, VV1777, VVA1573, VVP01, VVP21, VVP24. Tables S4 and S5 show a full list of differentially expressed genes in the various strains when grown in vitro and compared to each other.
Clusters of Orthologous Groups (COG) functional categories of expressed genes
The 123 genes fell into a variety of functional categories (Table 3 ). The largest group was the broad category of transcription-associated genes. Other genes were involved in signal transduction, cell motility, carbohydrate metabolism, intracellular trafficking and cell envelope biogenesis. Thirty-seven genes encoded hypothetical proteins from which the vast majority aligned to the reference sequence of the YJ016 plasmid. Twelve genes involved in transcription were differentially expressed during human infection, among them a gene encoding a LysR family transcriptional regulator (CMCP6 VV1_0456) which represents the most abundant type of transcriptional regulator in prokaryotes. LysR-type transcriptional regulators (LTTRs) regulate a diverse set of genes, including those involved in virulence, metabolism, quorum sensing and motility (Maddocks & Oyston, 2008) .
Six genes were involved in cell motility including three genes that encoded flagellar components (flagellin, flagellar basal body L-ring protein and flagellar basal body rod protein FlgC; CMCP6: VV1_0214, VV1_0220 and VV1_0225, respectively) found to be differentially expressed by~14-28 fold. The other genes in cognate operons were also expressed but to a lesser extent~2-2.5-fold (CMCP6: VV1_0215, VV1_0217, VV1_0219, VV1_0224 and VV1_0226) (Table  S2) . It is unclear why some of the genes were significantly expressed as compared with similar adjacent operons. Flagellum-based motility is crucial for a variety of processes in V. vulnificus including biofilm formation and pathogenesis (Jones & Oliver, 2009 ). Loss of flgC and flgE, using mutational analysis experiments, was associated with decreased motility, cellular adhesion and cytotoxicity (Lee et al., 2004a) . In addition, previous work showed that mutation in genes encoding pilA and pilD resulted in overall decreased cytotoxicity (Jones & Oliver, 2009; Paranjpye et al., 1998; Paranjpye & Strom, 2005) .
Several GGDEF family protein genes (CMCP6 genes VV1_2061, VV1_2228 and VV2_1509) and a Flp piluscoding region (CMCP6 genes VV1_2335 and VV1_2336) were also differentially expressed. The GGDEF domain is detected in many prokaryotic proteins, most of which are of unknown function and some are likely to possess nucleotide cyclase activity, such as the formation of the signalling molecule cyclic di-GMP (Pei & Grishin, 2001) . A recent study identified some genes in the GGDEF domain and genes encoding the Flp pilus-coding region as cluster-II-specific genes (MLST based clustering of V. vulnificus into cluster I and II, the last being dominated by strains isolated from infected humans) . Six genes encoding cell envelope biogenesis and outermembrane proteins were identified in the study. Perhaps the most important is the gene encoding the bacterial toxin, rtxA1 (CMCP6 VV2_0479 or identical YJ016 VVA1030). Repeats-in-toxin (RTX) are exoproteins identified in many Gram-negative bacteria; they consist of repeated structural subunits and their main feature is export across the bacterial envelope via the type I secretion. RTX proteins also comprise secreted proteases and lipases, which act as synergistic virulence factors causing tissue damage and/or eliciting the production of inflammatory mediators (Linhartová et al., 2010) . It has been recently confirmed that RtxA1 plays an important role in tissue damage and virulence caused by V. vulnificus (Jones & Oliver, 2009; Kim et al., 2008; Lee et al., 2007) .
Six genes were involved in carbohydrate transport and metabolism. The set of genes included a cluster involved in sialic acid catabolism and TRAP-transport system (CMCP6 genome VV2_ 0726, VV2_0729, VV2_0731, VV2_0732, VV2_0734 and VV2_0735). This set of genes has been identified in V. vulnificus genotypes associated with human infection (Morrison et al., 2012) and as cluster-II-specific genes . Four genes encoded peptide ABC transporter substrate-binding protein, arylsulfatase and arylsulfatase regulator (YJ016 genome VVA1630, VVA1632, VVA1633 and VVA1634). These genes are part of the 33 kb genomic island XII previously identified in biotype 3 strains and almost exclusively found in strains associated with human infection (Cohen et al., 2007) .
Four genes were involved in iron acquisition (CMCP6: VV2_829, VV2_843, VV2_844 and YJ016: VVA1310), encoding the phosphopantetheinyltransferase component of siderophore synthase, ferric vulnibactin outer-membrane receptor (vuuA), siderophore synthase amide synthase subunit and vulnibactin synthase amide synthase subunit, respectively. These genes encode proteins involved in iron acquisition systems. V. vulnificus utilizes vulnibactin (catechol sidephore) as its main pathway for iron acquisition (Alice et al., 2008; Kim et al., 2006) . Previous work that applied mutational gene experiments showed that mutation of vuuA resulted in reduced virulence compared with a wildtype strain (Webster & Litwin, 2000) .
Thirty-seven genes encoded hypothetical proteins; eight genes were shared by the two genomes (Table 2) . Four genes were unique to the CMCP6 genome and 25 to the YJ016 genome. The vast majority of genes encoding hypothetical proteins in YJ016 aligned to the reference sequence of the YJ016 plasmid.
Within the cluster of genes found to be differentially expressed in the human-pathogenic biotype 3, a significant number of genes were located on the small chromosome: RtxA1 (CMCP6 VV2_0479), a gene cluster involved in sialic acid catabolism and TRAP-transport system (CMCP6 genome VV2_ 0726, VV2_0729, VV2_0731, VV2_0732, VV2_0734 and VV2_0735); four genes encoding peptide ABC transporter substrate-binding protein, arylsulfatase and arylsulfatase regulator (YJ016 genome VVA1630, VVA1632, VVA1633 and VVA1634); and genes involved in iron acquisition (CMCP6 genome VV2_0829, VV2_0843 and VV2_0844). These observations are consistent with the mapping of a large fraction of the genes associated with pathogenicity to the small chromosome (Chen et al., 2003) .
The number of reads mapped to the reference sequence of the YJ016 plasmid was significantly higher in biotype 3 strains (human pathogenic and environmental) than in environmental biotype 1 strains (Table 1 ). This could suggest that biotype 3 strains may have acquired a set of genes originating from a plasmid.
Two recent studies that conducted comparative genome analyses on clinical and environmental strains, cluster-Iand cluster-II-specific strains, have identified several sets of genes that are specifically associated with virulence to humans Morrison et al., 2012) . The first identified 80 cluster-II-specific genes including a set of genes involved in Flp pilus-coding region, GGDEF proteins and genomic island XII. The other (Morrison et al., 2012) identified 278 genes associated with clinical strains including genes involved in sialic acid metabolism, mannitol fermentation and part of a type IV secretory pathway virB. Some of the genes identified in these studies were also found to be differentially expressed in the present study (Flp pilus-coding region, GGDEF proteins, genomic island XII and sialic acid metabolism).
Previous work showed that among V. vulnificus virulence factors, RtxA1 toxin plays a major role in cytotoxicity and disease pathogensis (Kim et al., 2008; Lee et al., 2007) and specifically in the invasion of V. vulnificus into the bloodstream from the gastrointestinal tract (Kim et al., 2008; Lee et al., 2008a) . Our data showed that during human infection RtxA1 gene expression exhibited an~60-fold change (log 2~5 .9), indicating that RtxA1 is differentially expressed also when the pathogen's port of the entry is the skin and not only during intestinal entry (Lee et al., 2008a) . To date, all the reported cases of V. vulnificus infections in Israel occurred after skin injuries during handling fish cultivated in inland fish farms.
The unique epidemiology of V. vulnificus in Israel implied that the outbreak was caused by a recombinant pathogenic strain that acquired capabilities to cause disease in humans that did not exist previously (Bisharat et al., 2005) . However, the nature of the mobile genetic elements that enabled a harmless nonpathogenic strain to cause disease in humans is still unclear. Thus far, none of the Israeli biotype 3 strains has been completely sequenced and therefore we cannot provide insights into any novel genes or transcripts existing in this population and missing from the reference genomes. It is noteworthy to mention that reads mapping the two biotype 3 strains (VV9-09 and 2321) to the reference genomes showed similar profiles, consistent with previous observations that emphasized the clonal nature of biotype 3 strains (Bisharat et al., 2007a) .
Our study has a few limitations; first, it lacks a biological replicate. Our conclusions were based on a clinical sample obtained from a single patient suffering from an invasive infection and need to be validated in similar settings. Second, as a non-experimental study we could not emulate the different stages of infection and determine which genes are differentially expressed during the various stages of human infection. Third, the lack of full genome sequence of biotype 3 strains is certainly a limitation; however, this may have affected our ability to draw any conclusions regarding novel transcripts that could be present in this biotype and missing in the reference genomes but it is unlikely to have adversely affected our conclusions.
In conclusion, we showed that during human infection V. vulnificus differentially expresses nearly 120 genes involved in various functional categories including transcription, signal transduction, cell motility, carbohydrate metabolism, intracellular trafficking and cell envelope biogenesis. Future research will focus on validating these results preferably from human clinical samples in similar settings.
